Federal spending on COVID-19 vaccine candidates tops $9 billion, spread among 7 companies
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
....
Submitted by mike kraft on
Dr. Anthony Fauci, the nation’s leading infectious disease expert, said a new study could explain the extraordinary range that people experience with the novel coronavirus, from having no symptoms at all or a mild case to hospitalization or death.
Submitted by mike kraft on
Submitted by mike kraft on
President Trump is considering new immigration regulations that would allow border officials to temporarily block American citizens and legal permanent residents from returning to the United States from abroad if authorities believe they may be infected with the coronavirus.
In recent months, Mr. Trump has imposed sweeping rules that ban entry by foreigners into the United States, citing the risk of allowing the virus to spread from hot spots abroad. But those rules have exempted two categories of people attempting to return: American citizens and non-citizens who have already established legal residence.
Submitted by mike kraft on
Submitted by mike kraft on
SAVANNAH, Ga. (AP) — A Georgia company falsely claimed a vitamin D product it was selling could lower the risk of becoming infected with COVID-19, federal prosecutors said.
Submitted by mike kraft on
Submitted by mike kraft on
...Mexico is battling one of the worst coronavirus outbreaks in the world, with more than 52,000 confirmed deaths, the third-highest toll of the pandemic. And its struggle has been made even harder by a pervasive phenomenon: a deeply rooted fear of hospitals.
The problem has long plagued nations overwhelmed by unfamiliar diseases. During the Ebola epidemic in 2014, many in Sierra Leone believed that hospitals had become hopeless death traps, leading sick people to stay home and inadvertently spread the disease to their families and neighbors.
Submitted by mike kraft on
DUBAI (Reuters) - Saudi Arabia will soon begin Phase III clinical trials on around 5,000 people for a COVID-19 vaccine developed by China’s CanSino Biologics Inc, a Saudi health ministry spokesman said on Sunday.